BCYC Competitors & Alternatives
Compare Bicycle Therapeutics Ltd with similar stocks in the same industry
Biotechnology
BCYC
Main Stock$4.35
Tradestie Score
59
Market Cap
$577.32M
Revenue Growth
-0.9%
Analyst Upside
+190.2%
Top Competitors
231 stocks in Biotechnology| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
ANNX
Annexon, Inc. Common Stock
|
$5.63
|
$332.96M | - | 60 | Compare |
|
REPL
Replimune Group, Inc.
|
$9.94
|
$328.62M | - | 57 | Compare |
|
EDIT
Editas Medicine, Inc. Common Stock
|
$3.16
|
$319.22M | - | 56 | Compare |
|
CTNM
Contineum Therapeutics, Inc. Class A Common Stock
|
$14.62
|
$308.74M | - | 60 | Compare |
|
CADL
Candel Therapeutics, Inc. Common Stock
|
$9.64
|
$304.12M | - | 57 | Compare |
|
JBIO
Jade Biosciences, Inc. Common Stock
|
$21.30
|
$297.23M | - | 59 | Compare |
|
TECX
Tectonic Therapeutic, Inc. Common Stock
|
$34.34
|
$293.03M | - | 60 | Compare |
|
OMER
Omeros Corporation
|
$10.01
|
$281.75M | 9.0 | 58 | Compare |
|
DBVT
DBV Technologies S.A.
|
$15.98
|
$275.54M | - | 57 | Compare |
|
ALLO
Allogene Therapeutics, Inc. Common Stock
|
$1.93
|
$275.13M | - | 44 | Compare |
More BCYC Analysis
Data updated: Jul 14, 2026 | Industry: Biotechnology (SIC 2834)
231 stocks in this industry